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The BASES Expert Statement on Exercise Training for People with 
Intermittent Claudication due to Peripheral Arterial Disease 
Produced on behalf of the British Association of Sport and Exercise Sciences by Dr Garry 
Tew, Dr Amy Harwood, Prof Lee Ingle, Prof Ian Chetter and Prof Patrick Doherty.  
Introduction 
Lower-limb peripheral arterial disease (PAD) is a type of cardiovascular disease in which the 
blood vessels (arteries) that carry blood to the legs and feet are hardened and narrowed or 
blocked by the build-up of fatty plaques (called atheroma). It affects around 13% of adults 
over 50 years old, and major risk factors for its development include smoking, diabetes 
mellitus, and dyslipidaemia (Morley, Sharma, Horsch & Hinchliffe, 2018). The presence of 
PAD itself is also a risk factor for other cardiovascular problems, such as angina, heart 
attack and stroke. This is because the underlying disease process, atherosclerosis, is a 
systemic process, meaning that blood vessels elsewhere in the body may also be affected.  
The most common symptom of PAD is intermittent claudication (IC), which is muscle pain or 
discomfort in the legs and/or buttocks brought on by walking and relieved within minutes on 
rest (Figure 1). It occurs due to an inability to increase blood flow (and oxygen delivery) 
sufficiently to match the metabolic demands of the lower-limb muscles during exercise. The 
walking distance or speed at which symptoms occur depends on multiple factors including 
the severity and site of the arterial disease, walking pace, terrain, incline and footwear. 
Nevertheless, IC can cause marked reductions in functional capacity and quality of life 
(Morley et al., 2018).  
Figure 1. Intermittent claudication due to peripheral arterial disease. Reproduced from 
Peripheral artery disease, Morley et al., 360, j5842, 2018 with permission from BMJ 
Publishing Group Ltd. Note: Iliac or femoral artery disease can cause symptoms at 
multiple distal muscle sites. 
Treatments for IC, aimed at relieving symptoms and reducing the risk of further 
cardiovascular disease, include lifestyle changes (e.g., stopping smoking, exercising more), 
vasoactive drugs (e.g. naftidrofuryl oxalate), and revascularisation (i.e. angioplasty or 
bypass surgery). In 2012, the United Kingdom’s National Institute of Health and Care 
Excellence (NICE) published a clinical guideline on the management of PAD, which stated 
that a supervised exercise programme should be offered as a first-line therapy for IC (NICE, 
2012). This statement provides an overview of the evidence on exercise training and 
recommendations for people delivering exercise programmes to this population.  
Evidence on exercise training 
Core outcome measures 
Walking ability and its impact on quality of life are the most important outcome measures of 
intervention to clinicians and patients. Measures of walking ability include pain-free and 
maximum walking distances (or times) obtained during standardised treadmill testing, and 
the distance covered in the 6-minute corridor walk test. The ‘Gardner’ treadmill test is 
commonly used, which involves a constant speed of 3.2 km/h and an increase in gradient of 
2% every 2 minutes. Several generic and condition-specific questionnaires have been used 
to assess quality of life, including the SF-36 and VascuQol, respectively.  
Effects of exercise training on walking ability and quality of life 
A recent Cochrane review concluded that there is high-quality evidence showing that 
exercise programmes (a variety of regimes) elicit important improvements in both pain-free 
and maximum walking distances compared with no-exercise control in people with IC (Lane, 
Harwood, Watson & Leng, 2017). A meta-analysis of 9 trials (n=391) showed a mean 
between-group difference in pain-free walking distance at follow-up of 82 m (95% CI 72–92 
m; follow-up ranging 6 weeks to 2 years). The corresponding difference for maximum 
walking distance was 120 m (95% CI 51–190 m; 10 trials, n=500). Improvements of this 
magnitude are likely to help with independence. 
The same review also reported that there was moderate-quality evidence for improvements 
in physical and mental aspects of quality of life, as assessed using the SF-36 (Lane et al., 
2017). A meta-analysis of data at 6 months of follow-up showed the physical component 
summary score to be 2 points higher in exercise versus control (95% CI 1 to 3; 5 trials, 
n=429). The corresponding difference for the mental component summary score was 4 
points (95% CI 3 to 5; 4 trials, n=343). Again, such differences have the potential to be 
clinically meaningful. 
Modes of exercise 
In most studies, exercise programmes have involved treadmill or track walking of sufficient 
intensity to bring on claudication pain. There is a strong evidence base for this type of 
training, and clinical guidelines around the world cite it as the preferred modality (e.g., NICE, 
2012). Alternate exercise modalities have not been extensively studied. However, a 
randomised trial of 104 participants provided evidence that both cycling and arm-cranking 
are viable alternatives for improving walking distances (Zwierska et al., 2005). These 
modalities may be useful for patients who are unwilling/unable to walk because of the pain 
encountered. Resistance training may have a complementary role (e.g., for improving 
muscular strength); however, it should not be used as a substitute for aerobic exercise 
because its impact on walking distances appears modest (e.g., McDermott et al., 2009).  
Supervision 
The systematic review of Gommans et al. (2014) the relationship between the ‘intensity’ of 
supervision of an exercise programme and the extent to which walking distances were 
improved. Thirty studies involving 1406 people with IC were included. Study treatment arms 
were categorised according to type of support: no exercise, walking advice, home-based 
exercise, and supervised exercise. The results indicated that the intensity of supervision was 
directly related to treatment effect, with supervised exercise training being superior to all 
other categories with respect to improvement in walking distances at all follow-ups (6 weeks, 
3 months, and 6 months). An economic evaluation to inform the NICE guidelines (NICE, 
2012) also indicated that supervised exercise is more cost-effective than either unsupervised 
exercise or angioplasty. 
Safety 
Gommans et al. (2015) explored the safety of supervised exercise training in people with IC 
by reviewing adverse event data from clinical trials. Seventy-four trials were included, 
representing 82,725 hours of training in 2,876 participants. Eight adverse events were 
reported, six of cardiac and two of non-cardiac origin, resulting in an all-cause complication 
rate of one event per 10,340 patient-hours. The authors concluded that supervised exercise 
training is safe for people with IC due to a low all-cause complication rate, and routine 
cardiac pre-screening is not required.  
Mechanisms 
The mechanisms underpinning the benefits of exercise training are incompletely understood. 
Regression of arterial stenoses appears unlikely to be implicated (Lane et al., 2017), 
whereas there are potential roles for improvements in maximum oxygen uptake, endothelial 
function, systemic inflammation and skeletal muscle oxidative capacity (Harwood, Cayton, 
Sarvanandan, Lane & Chetter, 2016). A summary of potential mechanisms is presented in 
Figure 2.  
!  
Figure 2. Potential mechanisms underpinning the benefits of lower-limb endurance 
exercise training on walking distance in people with IC, the relative importance of 
which is incompletely understood.  
Conclusions 
• Exercise training is a safe, effective and low-cost intervention for improving walking 
ability in people with IC. Additional benefits may include improvements in quality of 
life and cardiovascular health. 
• Clinical guidelines advocate exercise training as a primary therapy for IC. These 
guidelines also state that revascularisation or drug treatment options should only be 
considered if exercise training provides insufficient symptomatic relief. 
Recommendations 
• Exercise should ideally be delivered through an on-site supervised programme with 
clinical oversight. However, a facilitated, self-managed exercise programme involving 
behaviour change techniques is a reasonable alternative for people who prefer this 
approach or are unable to access supervised exercise. 
• Walking is the primary mode of exercise for improving walking ability and claudication 
symptoms. A structured programme of walking exercise at an intensity that elicits 
moderate-to-strong claudication pain should be conducted for a minimum of 3 
months, involving at least three, 30-60 minute sessions per week. Further 
recommendations on exercise training are provided in the Supplementary Table. 
• Patients should be clinically assessed and risk stratified to ensure that they do not 
have any contraindications to the exercise therapy and to document comorbidities 
that may need to be accounted for in the exercise programme.  
• Acute responses to exercise should be monitored to inform the exercise prescription, 
including heart rate, blood pressure, perceived exertion and claudication pain.  
• Programme entry and exit assessments should be performed to determine changes 
in patient-important outcomes, including walking distances and quality of life. 
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Supplementary Table. Details on exercise training in people with intermittent 
claudication 
Rationale 
for exercise
To improve walking capacity, claudication symptoms and quality of life, and 
for secondary prevention of cardiovascular disease
Provider The programme should have a designated clinical lead (e.g. vascular 
surgeon, physician or nurse specialist). Exercise professionals who wish to 
work in this area should possess the essential competencies and minimum 
qualifications specified in the following BACPR Position Statement: http://
www.bacpr.com/resources/51A_EPG_Position_Statement.pdf 
Mode of 
delivery
The exercise should ideally be delivered through an on-site supervised 
programme. The exercise prescription should be individually-tailored based 
on an initial assessment; however, several patients may be supervised at 
the same time. A facilitated, self-managed exercise programme with 
embedded behaviour change techniques is a reasonable alternative for 
people who have a preference for this approach or are unable to access an 
on-site programme, or for longer-term benefit after a supervised 
programme is completed. Details of a structured education programme that 
promotes self-managed walking exercise can be found here: 
www.york.ac.uk/healthsciences/research/trials/research/archive/sedric/ 
Unstructured, unsupervised exercise approaches that consist solely of 
basic advice to walk or exercise more are not effective.
Setting On-site programmes can be delivered in various settings including hospital- 
or community-based physiotherapy clinics or community exercise facilities. 
Self-managed programmes can be conducted in a setting that suits the 
individual.
Materials Assessment tools: Motorised treadmill with adjustable incline to allow 
incremental exercise testing (e.g. ‘Gardner’ protocol) to determine pain-free 
and maximum walking distances or, if unavailable, procedures and 
instructions for an alternative functional capacity test (e.g. 6-minute corridor 
walk test); questionnaires for assessing patient-perceived ambulatory 
function (e.g. WELCH questionnaire), and generic and condition-specific 
quality of life (e.g. SF-36 and VascuQol questionnaires, respectively). 
Optional – equipment to assess vascular status (e.g. ankle-brachial index) 
and cardiovascular disease risk (e.g. blood pressure, lipid profile).  
Exercise equipment: Motorised treadmills with adjustable incline or space 
for over-ground walking (preferably indoor and air-conditioned). Optional 
for aerobic exercise – upper and lower limb ergometers. Optional for 
resistance exercise – weights machines, dumbbells, resistance bands.  
Intensity-monitoring equipment: 5-point claudication pain scale, exertion 
scale (e.g. 6‒20 point Borg Rating of Perceived Exertion Scale), heart rate 
monitors, manual sphygmomanometer and stethoscope. 
W a l k i n g 
e x e r c i s e 
guidelines
Programme duration: At least 3 months  
Frequency: ≥3 times/week  
Claudication pain endpoint: Based on current evidence, patients should be 
advised to walk to the point of near-maximum leg pain (i.e. 4-5 on 
claudication pain scale); however, preliminary evidence suggests that 
walking only to the onset of ischemic leg pain may also be beneficial. 
Pattern: Following a warm-up period, the patient should walk at a speed 
and grade that induces claudication pain within 3-5 minutes. The patient is 
instructed to stop walking and rest when his or her claudication pain 
reaches a moderate-to-strong level. When the claudication has abated, the 
patient resumes walking until a moderate-to-strong claudication pain 
recurs. This cycle of exercise and rest is ideally repeated for at least 30 
minutes. In subsequent visits, the speed or grade of walking is increased if 
the patient is able to walk for ≥10 minutes without reaching moderate 
claudication pain.  
Duration per session: Many patients with intermittent claudication may 
need to start with just 10-15 minutes of walking exercise per session. In 
this situation, the duration of exercise should be increased by 5 minutes 
each week, until the patient is walking for at least 30 minutes per session. 
Patients who are able to walk for more than 30 minutes per session should 
be encouraged to increase the exercise duration to 45-60 minutes. 
Upper and 
lower limb 
ergometry
May be considered as alternative aerobic exercise strategies for improving 
walking ability and quality of life. May also have the potential to provide a 
greater cardiorespiratory stimulus than walking exercise in individuals with 
severe claudication.  
Example protocol: Ten sets of 2 minutes of upper or lower extremity 
ergometry conducted twice weekly for at least 3 months.
Resistance 
exercise
May be considered as complementary (e.g. for targeting improved strength 
or reduced falls risk), but not as a replacement for aerobic exercise 
because its impact on walking ability appears modest at best.  
Example protocol: Moderate-to-vigorous intensity (Borg exertion rating of 
14-16), 8-10 exercises targeting the major muscle groups, 2-4 sets of 
10-15 repetitions per set, 2-3 sessions per week. 
Other Circuit-based training may be a practical way of delivering a combination of 
aerobic and resistance exercises when circumstances necessitate group-
based training. 
S a f e t y 
issues
An initial risk assessment should occur as per Appendix E of the following 
ACPICR Standards document: http://acpicr.com/sites/default/files/
ACPICR%20Standards%202015.pdf Exercise is contraindicated by foot 
ulcers and limb pain at rest (i.e. critical limb ischaemia). As patients 
increase their walking ability, there is the possibility that cardiac signs and 
symptoms may appear (e.g., dysrhythmia, angina, or ST-segment 
depression). These events should prompt clinical assessment.
